ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report) shares passed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $0.07 and traded as low as $0.01. ProPhase Labs shares last traded at $0.0103, with a volume of 18,265 shares.
ProPhase Labs Stock Performance
The firm has a fifty day moving average of $0.02 and a 200 day moving average of $0.07. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.14 and a quick ratio of 0.14. The stock has a market capitalization of $171,207.00, a price-to-earnings ratio of -0.00 and a beta of 0.13.
ProPhase Labs Company Profile
ProPhase Labs, Inc is a diversified health and wellness company focused on diagnostics, genomics, consumer healthcare products and related biopharmaceutical opportunities. The company operates through businesses that develop and commercialize products and services intended to support disease detection, personalized health information and consumer wellness.
Its consumer healthcare operations include Cold-EEZE zinc-based products, which are marketed in forms such as lozenges and oral sprays for common-cold symptom support.
Recommended Stories
- Five stocks we like better than ProPhase Labs
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.
